Prokinin Tablet & Susp Patient Information Leaflet

download Prokinin Tablet & Susp Patient Information Leaflet

of 1

Transcript of Prokinin Tablet & Susp Patient Information Leaflet

  • 7/23/2019 Prokinin Tablet & Susp Patient Information Leaflet

    1/1

    rokinin

    omperid one Table ts and Suspens ion

    Composition:

    Prokinln Tablets: Each tablet contains to mg Domperidone.

    Proklnln suspension: Each 5m1contains 5 mg Domperidone.

    Properties:

    Domperidone is a dopamine-receptor blocking agent. Its action

    on the dopamine-receptors in the chemo-emetic trigger zone

    produces an anti-emetic effect. It does not cross the blood-brain

    barrier to any appreciable degree.

    Domperidone increases the duration 01 antral and duodenal

    CQl)tractiQ Uo increase gastric emptying,. but it does not alter

    g as tr ic s ec re tio n s a nd h as n o ef fe ct o n in tr ac ra nial p res su re o r in

    the cardiovascular system.

    Domperidone is rapidly absorbed, with peak plasma

    concentration at approximately 1 hour after oral administration,

    the bioavailability is low (approximately 15%) due to first pass

    hepatic

    and

    intestinal metabolism, it is 91-93 bound to plasma

    proteins, the plasma half life after a single oral dose is 7-9 hours

    in healthy patients but it is prolonged in patients with sever renal

    insufficiency.

    Indications:

    A) The dyspeptJc symptom complex that is often assooateo With

    delayed gastric emptying, gastro-oesophageal reflux and

    oesophagitis:

    epigastric sense of fullness, early satiety, feel ing of abdominal

    distension, upper abdominal pain;

    bloating, eructation, flatulence;

    n au sea an d vom i t in g

    heartburn with or without regurgitations of gastric contents in

    the mouth.

    b) Nausea and vomiting of functional, organIC_ Infectious or

    dietetic origin or .induced b radiotherapy therapy_ A

    SPOCllIIC'lnOica . is nausea . dopa.

    agonists, as used in Parkinson's tflSea5e (such as L- dopa and

    brornocriptine).

    Contraindications:

    Proklnin is contraindicated for patients with known

    hypersensitivity to any of tts components.

    Dompendone should not be used whenever stimulation of gastric

    motilijy is to be avoided or could be harmful, ego In case of

    gastro-intestinal haemorrhage, obstruction or perforation.

    Domperidone is contraindicated.Ja.patients wilb a prolactin-

    releasing pitui tary tumor (prolactinoma).

    Precautions:

    Domperidone given to animals at doses up ID 160 mgI